Viewing StudyNCT06238921



Ignite Creation Date: 2024-05-06 @ 8:02 PM
Last Modification Date: 2024-10-26 @ 3:19 PM
Study NCT ID: NCT06238921
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-07-15
First Post: 2024-01-25

Brief Title: Sacituzumab Govitecan and Zimberelimab wSRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases
Sponsor: H Lee Moffitt Cancer Center and Research Institute
Organization: H Lee Moffitt Cancer Center and Research Institute

Key Dates - Follows AllAPIJSON File Order

Start Date: 2024-08
Start Date Type: ESTIMATED
Primary Completion Date: 2027-02
Primary Completion Date Type: ESTIMATED
Completion Date: 2027-02
Completion Date Type: ESTIMATED
First Submit Date: 2024-01-25
First Submit QC Date: January 25 2024
Study First Post Date: 2024-02-02
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-09-03
Last Update Post Date: 2024-07-15
Last Update Post Date Type: ESTIMATED